Last reviewed · How we verify
CpG-adjuvanted HBV Vaccine
At a glance
| Generic name | CpG-adjuvanted HBV Vaccine |
|---|---|
| Sponsor | NYU Langone Health |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Understanding Poor Vaccine Responses to Hepatitis B Vaccination (PHASE4)
- TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CpG-adjuvanted HBV Vaccine CI brief — competitive landscape report
- CpG-adjuvanted HBV Vaccine updates RSS · CI watch RSS
- NYU Langone Health portfolio CI